Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Kevin F. Mclaughlin currently holds 50,000 shares of ACCELERON PHARMA INC (XLRN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Kevin F. Mclaughlin has been a net seller of XLRN stock. They have purchased $125.0K and sold $29.7M worth of shares.
Kevin F. Mclaughlin's most recent insider trade was on Nov 19, 2025, when they purchased 50,000 shares at $2.50 per share.
Kevin F. Mclaughlin serves as Executive at ACCELERON PHARMA INC (XLRN). They have executed 233 insider transactions totaling $29.9M over their tenure at the company.
Kevin F. Mclaughlin holds the position of Executive at ACCELERON PHARMA INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Kevin F. Mclaughlin has shown a selling trading pattern, with $125.0K in total purchases and $29.7M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Kevin F. Mclaughlin was on Dec 14, 2020, when they sold $5.5M worth of XLRN shares. This transaction involved 42,528 shares at $130.14 per share.
Kevin F. Mclaughlin currently owns 50,000 shares of ACCELERON PHARMA INC (XLRN), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Kevin F. Mclaughlin's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Kevin F. Mclaughlin has 233 Form 4 filings on record as an insider at ACCELERON PHARMA INC.
Set alerts for Kevin F. Mclaughlin and 40,000+ other insiders.